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affecting food intake in male C57BL6 mice
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Background: Quinine is a natural molecule commonly used as a flavouring agent in tonic water. Diet
supplementation with quinine leads to decreased body weight and food intake in rats. Quinine is an in vitro inhibitor
of Trpm5, a cation channel expressed in taste bud cells, the gastrointestinal tract and pancreas. The objective of this
work is to determine the effect of diet supplementation with quinine on body weight and body composition in male
mice, to investigate its mechanism of action, and whether the effect is mediated through Trpm5.
Results: Compared with mice consuming AIN, a regular balanced diet, mice consuming AIN diet supplemented with
0.1% quinine gained less weight (2.89 ± 0.30 g vs 5.39 ± 0.50 g) and less fat mass (2.22 ± 0.26 g vs 4.33 ± 0.43 g) after
13 weeks of diet, and had lower blood glucose and plasma triglycerides. There was no difference in food intake
between the mice consuming quinine supplemented diet and those consuming control diet. Trpm5 knockout mice
gained less fat mass than wild-type mice. There was a trend for a diet-genotype interaction for body weight and body
weight gain, with the effect of quinine less pronounced in the Trpm5 KO than in the WT background. Faecal weight,
energy and lipid contents were higher in quinine fed mice compared to regular AIN fed mice and in Trpm5 KO mice
compared to wild type mice.
Conclusion: Quinine contributes to weight control in male C57BL6 mice without affecting food intake. A partial
contribution of Trpm5 to quinine dependent body weight control is suggested.
Keywords: Obesity, Food intake, Fat, Body composition, Gastrointestinal tractBackground
Quinine is a natural molecule extracted from the bark of
the cinchona tree commonly used as a flavoring agent in
tonic water and bitter lemon and, at higher doses, for
the treatment of some forms of malaria. Consumption of
quinine by rats strongly reduces food intake and body
weight [1-7]. The decrease in food intake was initially
attributed to the intense bitter taste of quinine but it
was later shown that diminished food intake is observed
with rats consuming a diet supplemented with quinine,
but not with a diet supplemented with iso-bitter sucrose
octaacetate, suggesting that palatability is not the only
cause of decreased food intake in rats consuming quin-
ine in the diet [1]. Furthermore it is unclear from the rat
experiments whether there is a direct effect of quinine
on body weight, independently of food intake. Quinine
was recently shown to inhibit the activity of Trpm5 [8] a* Correspondence: sami.damak@rdls.nestle.com
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distribution, and reproduction in any mediumcalcium activated cation channel expressed in the taste
buds [9], gastrointestinal tract [10], pancreas [11] and
other hollow organs, involved in taste signaling and glu-
cose homeostasis. Here we present evidence that quinine
controls body weight independently of food intake in
male C57BL6 mice and investigate its mechanism of ac-
tion, including a possible role of Trpm5 in mediating the
effect of quinine on body weight control.Results
Initially we planned to use encapsulated quinine to mask
its bitterness and eliminate any potential impact on food
intake caused by unpalatable diet. During the course of
optimising the encapsulation procedure, we found that
C57BL6 mice consume equal amounts of regular diet or
non-encapsulated quinine supplemented diet (data not
shown). Therefore the encapsulation approach was
dropped and all subsequent experiments were carried
out with regular, non encapsulated quinine.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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http://www.biomedcentral.com/1472-6793/13/5Quinine fed mice gain less body weight and fat mass
than mice on a regular diet (study 1)
We supplemented a regular balanced diet (AIN) of wild
type male mice with quinine, and measured their body
weight and fat mass for 13 weeks. We tested quinine con-
centrations of 0.01%, which is the highest concentration
allowed in drinks for human consumption, and 0.1%. Com-
pared with wild type mice consuming regular diet (WT
control), wild-type mice consuming 0.1% quinine supple-
mented diet (WT quinine) had lower body weight (p < 0.05,
Figure 1A) and lower fat mass (p < 0.01) (Figure 1B),
whereas there was no significant difference in lean mass be-
tween WT control and WT quinine (Figure 1C). WT quin-
ine mice gained less weight (2.89 ± 0.30 g vs 5.39 ± 0.50 g p














































Figure 1 Body weight, fat and lean mass of WT mice on control diet,
weight and fat mass gains with 0.1% quinine but not with 0.01% qui0.43 g p < 0.001, Figure 1E) and less lean mass (1.07 ±
0.18 g vs 1.82 ± 0.20 g p < 0.05) than WT control mice.
There was no significant difference in body weight, fat mass
or lean mass between WT control and WT mice consum-
ing 0.01% quinine (Figure 1).
Food intake is not different between quinine fed mice
and mice fed a regular diet (study 1)
There was no significant difference in cumulative food in-
take between the WT control mice, WT quinine mice,
and mice fed a diet supplemented with 0.01% quinine
(238 ± 3.5 g, 235 ± 3.2 g, 248 ± 4.8 g, respectively,
Figure 2A). A preliminary experiment showed that the
percentage of waste was very small, and real daily food in-






























































diet + 0.1% quinine, or diet + 0.01% quinine, showing lower body
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http://www.biomedcentral.com/1472-6793/13/5significantly different between groups, although there was
a trend for increased real food intake by animals fed quin-
ine supplemented diets (Figure 2B). When given the
choice between two diets with or without quinine (Study
5), wild type mice avoid the quinine containing diet in
favour of the regular diet, demonstrating aversion for the
bitter taste of quinine (Figure 1C). In contrast, when given
only one choice, mice consume the same amounts of
regular or quinine supplemented diet (Figure 2B). Thus
the decreased body weight and fat mass gains observed in
the WT quinine mice are not caused by diminished intake






BMetabolic parameters are improved by treatment with
quinine (study 1)
Compared with WT control mice, blood glucose and
plasma triglycerides were lower in WT quinine mice (p
< 0.005, and p < 0.01, respectively, Figure 3). Blood glu-
cose was lower in Trpm5 KO mice than in control
(Study 2, p < 0.05). There was no significant difference in
plasma free fatty acids and insulin between WT control




















*** ***Effect of diet supplementation with 0.1% quinine on
body weight and body composition of wild type and
Trpm5 knockout mice (study 2)
Since quinine inhibits Trpm5 in vitro, in this experiment
we investigated whether the effect of quinine on body
weight and body composition was mediated through
Trpm5. To this effect, we measured body weight and
composition of WT control, WT quinine, Trpm5 KO
mice with regular AIN diet (KO control) and Trpm5 KO
mice with 0.1% quinine supplemented AIN diet (KO
quinine) and compared the effect of genotype (WT vs
KO), diet (control vs quinine) and genotype*diet inter-
action. The means for body weight gain and fat mass
gain for each group are given in Table 1. There was a
significant effect of diet on body weight repeated mea-
surements and gain (control > quinine, p < 0.01), but no
effect of genotype. There was a significant effect of diet
on fat mass repeated measurements and gain (Control >
quinine, p < 0.001). There was a significant effect of
genotype on fat mass gain (WT > KO, p < 0.05). There
was a trend for an interaction diet*genotype for repeated
measurements of body weight (p = 0.10) and body
weight gain (p = 0.12) (Figure 4). These data confirm the
effect of quinine on body weight and fat mass found in
study 1. Trpm5 KO mice gain less fat mass than WT
animals. The diet*genotype interaction trend suggests
that part of the effect of quinine on body weight and fat
mass may be Trpm5-dependent. There was no signifi-
cant effect of genotype or diet on lean mass gain (Values
in Table 1).
Figure 2 Food intake of WT mice on AIN diet with or without
quinine. A. Cumulative food intake of mice on control AIN diet, AIN
diet + 0.1% quinine, or AIN diet + 0.01 % quinine, showing no
difference between any of the groups. B. Daily real food intake and
food waste of wild type mice consuming AIN diet, or AIN diet
supplemented with 0.1% or 0.01% quinine. Real food intake was
calculated by subtracting waste from measured food intake. There is
no significant difference between groups with different diets. There
is a trend for increased real food intake by animals fed quinine
supplemented diets. C. Diet preference tests, comparing AIN diet
and AIN diet supplemented with either 0.01% or 0.1% quinine,
showing aversion for the quinine supplemented diets.
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(study 2)
After 13 weeks of consuming a diet supplemented with
quinine, mice were switched to a control diet for 4 weeks.
During that period there was no significant effect on
weight gain of diet and a strong trend for genotype (p =
0.087) with no significant interaction (values in Table 1).
Thus quinine treated mice do not regain weight after
being switched to regular diet, whereas Trpm5 KO mice
tend to gain less weight than WT mice.
Effect of quinine and Trpm5 KO on energy balance
(study 2)
Faeces from WT control, WT quinine, KO control and
KO quinine mice were collected and their total energy,
fat and protein contents were measured (Figure 5). The
amount of dried faeces per 24 h, faecal energy per gram
of faeces, faecal energy per 24 h, faecal free fatty acids,
faecal triglycerides, and faecal cholesterol were higher in
mice receiving the quinine supplemented diet than those
on control diet (Figure 5). The amount of dried faeces
per 24 h, faecal energy per 24 h, faecal free fatty acids,
and faecal cholesterol were higher in Trpm5 KO mice
than in control mice (Figure 5). Phospholipids were not
detectable in the faeces. There was no significant effect




































Figure 3 Blood glucose, plasma insulin, triglycerides (TG), and free fa
fed (control) WT mice, and from Trpm5 KO mice fed a control diet (K
than in quinine or Trpm5 KO mice. There is no difference in plasma insulin
control than in quinine. * p < 0.05, **p < 0.01, ***p < 0.001.was no genotype*diet interaction for any of those
parameters.
The effect of quinine on fat mass gain is small and short
lived in diet-induced obese mice fed a high fat diet
(study 3)
The aim of this experiment was to determine if supple-
mentation of the diet of obese mice with quinine would
lead to weight loss. Diet-induced obese mice were fed a
45% fat diet with or without supplementation with 0.1%
quinine for 12 weeks. WT quinine mice gained less
weight than WT control mice, but fat mass was lower in
WT quinine mice only after 6 weeks of exposure to the
experimental diet (p < 0.05, Figure 6). At week 11, there
was no significant difference in fat mass. Lean mass was
lower in quinine-treated mice at week 6 and week 11 (p
< 0.01 and p < 0.05, respectively). Cumulative food intake
was lower in mice fed quinine supplemented high fat
diet than in control (177 ± 2.4 g vs 189 ± 3.1 g p < 0.05).
Thus when high fat diet is used, the effect of quinine on
fat mass is small, short lived and caused at least in part
by diminished food intake.
Twenty four-hour energy expenditure and activity are not
different between WT control, WT quinine, and KO
control mice (study 4)
Twenty four-hour energy expenditure, respiratory quo-
tient and activity were measured after mice were fed the
experimental diets for two weeks and did not differ be-
tween WT control, WT quinine and KO control fed AIN
(Figure 7) or high fat diet (not shown).
Markers of hepatic toxicity and of systemic inflammation
are normal in quinine-fed mice (study 1)
To rule out the possibility that the diminished body
weight gain observed in the quinine fed animals was
caused by liver toxicity or general inflammation, we mea-



















tty acids (FFA) from 0.1% quinine fed (quinine) and control diet
O) for blood glucose. Blood glucose is more elevated in the control
between control and quinine. TG, but not FFA are more elevated in
Table 1 Results of study 2, showing means ± SEM for gains in body weight, fat mass, lean mass and body weight after
quinine removal from the diet in the four experimental groups of mice
Body weight gain (g) Fat mass gain (g) Lean mass gain (g) Body weight gain after quinine removal (g)
WT control 4.90 ± 0.63 3.35 ± 0.46 1.19 ± 0.14 2.14 ± 0.22
WT quinine 2.86 ± 0.31 1.61 ± 0.21 0.66 ± 0.19 2.00 ± 0.28
KO control 3.84 ± 0.33 2.19 ± 0.38 1.13 ± 0.30 1.39 ± 0.36
KO quinine 3.12 ± 0.28 1.38 ± 0.23 1.38 ± 0.31 1.78 ± 0.24
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http://www.biomedcentral.com/1472-6793/13/5aspartate-amino-transferase (AST) and alanine-amino-
transferase (ALT), which are elevated in case of hepatic
toxicity, were within normal range in mice fed a diet con-
taining 0.1% quinine and not significantly different from
control (AST: 47.2 ± 1.5 U/L and 43.2 ± 1 U/L; ALT 20.9
± 1.6 U/L and 18.2 ± 0.7 U/L for control and quinine,
respectively).
Two mice in the control group and one mouse in the
quinine fed group had elevated INF-γ, IL-10, IL-12p70,
and IL-6, suggesting that those three mice had systemic
inflammation (Figure 8). For all other mice the levels of
IL-1β, IL-12p70, INF-γ, IL-6, and TNF-α were either un-
detectable, in most cases, or slightly above the detection
threshold. The levels of KC and IL-10 were detectable












































WT Control WT Quinine KO Control KO Quinine
Genotype: p=0.34
Diet:          p=0.002
Interaction: p=0.120
Figure 4 Body weight and fat mass of WT and Trpm5 knockout mice
of diet, genotype and the interaction are shown below each graph. Body w
mass gain is significantly lower in Trpm5 KO mice. There is a trend for inte
larger in the WT than in the knockout background.difference between control and quinine (medians for
control and quinine, respectively, KC: 86 pg/ml and
74 pg/ml; IL-10: 19 pg/ml and 13 pg/ml).
Together these data show that there is no evidence of
liver toxicity or systemic inflammation associated with
quinine supplemented diet.
Discussion
In this study, we tested the effect of quinine on mouse
body weight and body composition and investigated pos-
sible mechanisms, including the role of Trpm5. Mice
consuming a balanced diet supplemented with 0.1%
quinine gained less fat mass than mice on a regular diet
and maintained this difference at least for one month



































on control diet or diet + 0.1% quinine. The p values for the effects
eight and fat mass gains are significantly diminished by quinine. Fat




























































































Genotype: p=0.001                      p=0.16 p=0.001
Diet:           p=0.001 p=0.002 p<0.001
Interaction: p=0.31 p=0.223 p=0.194
Genotype: p= 0.30                     p= 0.001 p=0.17 p=0.02
Diet:           p= 0.82 p<0.001 p<0.001 p<0.001
Interaction: p= 0.80 p=0.33 p=0.63 p=0.08
Figure 5 Faecal weight, and calorie, nitrogen and lipid contents of faeces from WT and Trpm5 KO mice consuming a regular diet or a
0.1% quinine supplemented diet. The p values for the effects of diet, genotype and the diet*genotype interaction are shown below each
graph. FFA: free fatty acids, TG: triglycerides, CHL: cholesterol.
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in food intake and body weight were conducted using rats
[1-7]. Quinine has an intense bitter taste to humans and is
aversive to rodents. Adding quinine to the diet of rats
results in a large decrease in food intake accompanied by
diminished body weight. The decrease in food intake is
observed with rats consuming a diet supplemented with
quinine, but not with a diet supplemented with iso-bitter
sucrose octaacetate, suggesting that palatability is not the
only cause of decreased food intake in rats consuming
quinine in the diet [1]. Our results differ from those
obtained with rats in that food intake was not diminished
in mice consuming quinine supplemented diet compared
to those consuming regular diet. In preliminary experi-
ments we found that when given the choice between two
diets with or without 0.1% quinine, wild type mice avoid
the quinine containing diet in favour of the regular diet,
demonstrating aversion for the bitter taste of quinine. Incontrast, when given only one choice, mice consume the
same amounts of regular or quinine supplemented diet.
Food intake was carefully measured in studies 1–4 and
the results were consistent for all the studies where AIN
diet was used. We also measured waste in a separate ex-
periment and found that it was minimal, and real food in-
take was not affected by addition of quinine. Thus,
whereas decreased food intake explains part of the quinine
induced weight loss in rats, it does not in regular diet fed
mice. Rats are more likely to decrease their food intake
because of palatability than mice.
Smaller gain in body weight and fat mass may be caused
by increased energy expenditure, due to increased metabol-
ism or activity, or decreased nutrient ingestion and/or ab-
sorption. We found an increase of total faeces, faecal
energy and lipid content in the quinine treated mice com-
pared to mice on control diet. There was no difference in
protein content. Faecal carbohydrate content cannot be





























Figure 6 Body weight and body composition of obese wild
type mice receiving control or 0.1% quinine supplemented
high fat diet. Measures were taken at the beginning, 6 weeks and
11 weeks after the onset of the study. At 6 weeks after onset of the
experiment, both lean and fat mass are lower in the quinine treated
group, whereas at week 11 only lean mass is lower. *
p < 0.05, **p < 0.01.
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http://www.biomedcentral.com/1472-6793/13/5directly measured since sugars are converted in the colon
by the gut microflora into short chain fatty acids [12]. The
largest contribution to faecal lipid difference between quin-
ine treated and control mice was from free fatty acids, sug-
gesting that absorption of fatty acids, not digestion of
triglycerides is deregulated by quinine treatment. The 24 h
faecal weight is larger in quinine fed mice than in mice fed
regular diet. The difference (~20 mg) cannot be accounted
for by the difference in lipid content, as the difference in
faecal FFA between quinine fed mice and control diet fed
mice is only ~0.1 mg. The bulk of the difference in faecal
weight most likely results from differences in the amount
of undigested starch. Indirect calorimetry and measure-
ment of activity showed no difference between WTcontrol,
WT quinine and KO control. Altogether these data suggest
that quinine administration deregulates intestinal nutrientabsorption rather than energy expenditure. All mice, in-
cluding quinine fed animals, looked healthy without any
signs of distress during the experiment. There were no bio-
logical signs of liver toxicity, and biological signs of sys-
temic inflammation were found in two mice in the control
group and one mouse fed quinine. Thus, it is unlikely that
insults to visceral organs may have accounted for the
diminished weight gain observed in quinine fed mice.
Quinine-fed mice did not regain weight during a 4-
week follow up period after quinine-containing diet was
replaced with a regular AIN diet. This fact is of clinical
relevance. If quinine were to be investigated as a body
weight control measure in humans, it may not be neces-
sary to provide it on a continuous basis.
Is the effect of quinine on body weight and body com-
position Trpm5 dependent? For body weight and body
weight gain there is a trend for an interaction genotype-
diet, with a clear effect of quinine on WT type and a
very small non significant effect on the knockout. This
trend suggests the existence of a Trpm5 and quinine-
dependent mechanism of body weight and fat mass gain
prevention. Total faeces, caloric and lipid faecal contents
are increased by quinine treatment both in the KO and
WT backgrounds (no interaction diet-genotype) indicat-
ing that they represent Trpm5-independent quinine-
dependent mechanisms of body weight control. Quinine
is likely to act on multiple targets, including possibly
Trpm5, bitter taste receptors [13], which are expressed
in the gastrointestinal tract [14], potassium channels
[15,16] or by direct activation of G-proteins [17].
What is then the Trpm5-dependent mechanism of
diminished body weight gain? Trpm5 is expressed in the
taste buds [9], gastrointestinal tract [10], pancreas [11]
and other hollow organs. In the gastrointestinal tract
Trpm5 is expressed in solitary cells disseminated
throughout the gut, some of which also co-express T1rs,
the receptors for sweet and umami tastes, suggesting
that they might be chemosensory cells. Intestinal Trpm5
expressing cells produce endogenous opioids (β-endor-
phin and Met-enkephalin) and uroguanylin, and they se-
crete β-endorphin in response to various stimuli,
particularly hypertonic stimuli, in a Trpm5-dependent
fashion [18]. Opioids are well known to inhibit intestinal
motility. It is tempting to speculate that inactivation of
Trpm5 by gene knockout leads to increased intestinal
motility through diminished release of β-endorphin
thereby reducing intestinal nutrient uptake. Consistent
with this hypothesis increased faecal weight, and faecal
caloric and lipid contents are found in Trpm5 KO mice
compared to wild type mice, although the differences are
less marked as with quinine versus control. Given that
the Trpm5-dependent prevention of weight gain takes
place over a very long period, it is understandable that
its underlying physiological changes are subtle. Quinine,
Activity Energy expenditure














































Figure 7 Activity and energy expenditure. Twenty-four hour activity shown as mean events per 25 minute period, and energy expenditure of AIN-fed
WT control, WT quinine and KO control mice show no difference between conditions. For energy expenditure, the dark period is represented by a
grey box.
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http://www.biomedcentral.com/1472-6793/13/5on the other hand decreases gastrointestinal transit [19]
and therefore would increase faecal weight, energy and
lipids through a mechanism independent of Trpm5
inhibition.
Quinine mediated control of body weight and fat mass
is clearly observed in mice fed a balanced diet (AIN) but
is less clear when mice are fed high fat diet and inter-
pretation of the results is confounded by lower food in-
take in the quinine group. Mice fed high fat diet overeat
because of the palatability of fat, and this overeating may
have been smaller in the quinine group because of
bitterness.
Conclusion
Our data show that quinine contributes to the control of
body weight and fat mass without impacting food intake


























Figure 8 inflammation markers. Plasma cytokine concentrations in
individual WT mice fed a diet containing 0.1% quinine or a control
diet showing elevated levels of cytokines in two control mice and
one quinine fed mouse, but no difference in the levels of cytokines




All experiments were conducted according to Swiss ani-
mal experimentation laws and guidelines and were
approved by an internal animal experimentation ethics
committee and by the Veterinary Office of the Canton
de Vaud. Mice were maintained at 22 degrees C with a
12 h dark-12 h light cycle.
Study design
Study 1: body weight and body composition of wild-type
mice consuming quinine supplemented diet
Wild type C57BL6/J male mice three months old at the
beginning of the experiment were used. They were fed a
balanced semi synthetic diet (AIN 93 G, 64% calories
from carbohydrates, 20% from proteins, 16% from fat,
Diet # D10012G, Research Diets, New Brunswick, NJ,
USA) with or without different doses of quinine, for
13 weeks. Three groups of 20 mice each were studied:
A. Wild type fed AIN 93 G diet; B. Wild type fed AIN
93 G diet supplemented with 0.1% quinine HCl; C. Wild
type fed AIN 93 G diet supplemented with 0.01% quin-
ine HCl. 0.01% quinine corresponds to the maximal con-
centration allowed in drinks for human consumption.
Groups were matched for fat mass assessed by NMR at
the beginning of the study.
Body weight, food and fluid intake were measured weekly
throughout the study. Body composition was measured at
the beginning of the study, and on week 4, 8 and 12. At the
end of week 13, mice were fasted for 6 hours, a drop of
blood was collected by making a small incision in the tail
vein, from which blood glucose was measured, then the
mice were anesthetised with 3% isoflorane and blood was
Cettour-Rose et al. BMC Physiology 2013, 13:5 Page 9 of 11
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plasma insulin, aspartate-amino-transferase (AST), alanine-
amino-transferase (ALT), pro-inflammatory cytokines, free
fatty acids and triglycerides.
Study 2: body weight and body composition of WT and
Trpm5 KO mice consuming quinine supplemented diet
The aims of this study were to: 1. confirming the results
of Study 1; 2. determine if the effect of quinine on body
weight was mediated by Trpm5; 3. Investigate the effect
of quinine on energy intake; 4. Determine if mice regain
weight once quinine is removed from the diet.
Wild type and Trpm5 KO male mice three months old
at the beginning of the experiment were used. Trpm5
knockout (KO) mice (obtained from Deltagen, San
Mateo, CA, USA) were described in [20]. The KO mice
were backcrossed for six generations into C57BL6/J
background. Mice were fed a balanced semi synthetic
diet (AIN 93 G) with or without 0.1% quinine for
13 weeks. In order to determine if the effect on body
weight persists when the mice are no longer fed quinine,
all mice were fed AIN 93 G without quinine after the
initial 13-week trial for an additional 4 weeks. Four
groups of 15 male mice each were studied: A. Wild type
C57BL6/J fed AIN 93 G diet (WT control); B. Wild type
C57BL6/J fed AIN 93 G diet supplemented with 0.1%
quinine HCl (WT quinine); C. Trpm5 KO fed AIN 93 G
diet (KO control); D. Trpm5 KO fed AIN 93 G diet sup-
plemented with 0.1% quinine HCl (KO quinine). Groups
A and C were matched with groups B and D, respect-
ively, for fat mass and body weight at the beginning of
the study.
Body weight, food and fluid intake were measured
weekly throughout the study. Body composition was
measured at the beginning of the study, on week 7 and
on week 13. On weeks 1, 7 and 13, mice were placed on
a grid above a piece of cardboard covering the bottom of
the cage for 72 hours. The faeces were separated from
food crumbs and powder, and collected daily for meas-
urement of weight, macronutrient content and direct
calorimetry. On week 13 blood glucose was measured
from a drop of blood collected by making a small inci-
sion in the tail vein.
Study 3: body weight and body composition of wild-type
obese mice consuming quinine supplemented high fat diet
The aim of this experiment was to determine if supple-
mentation with quinine of the diet of obese mice would
lead to weight loss. Seven-week old wild type male
C57BL6/J mice were fed a diet with 60% calories from
fat (research diets D12492) for 9 weeks to make them
obese. They were then fed a 45% high fat diet (research
Diets D12451) for one week in order to maintain their
weight and to get habituated to the 45% fat diet. Thenone group of 19 mice continued to be fed 45% high fat
diet (control), and the other group of 19 mice was fed
45% high fat diet containing 0.1% quinine-HCl for
12 weeks. Groups were matched for fat mass assessed by
NMR at the beginning of the study.
Body weight, food and fluid intake were measured
weekly throughout the study. Body composition was
measured at the beginning of the study, and on week 6
and 11.
Study 4: energy expenditure and activity
Three groups of 10 male mice 3 month old and weight
matched, were tested: A. Wild type mice without quin-
ine, B. Wild type mice with 0.1% quinine HCl, C. Trpm5
KO mice without quinine.
Mice were fed a balanced diet (AIN-93 G) with or with-
out 0.1% quinine HCl for two weeks, then were fed high
fat diet (60% energy from fat, Research Diets #12492) with
or without 0.1% quinine HCl for two weeks. Energy ex-
penditure was measured after each two-week period; the
mice were placed into metabolic cages for a 24-hour accli-
mation period then VO2, VCO2, respiratory quotient (RQ)
and activity were measured over 24 hours using an Oxylet
system (Panlab, Barcelona, Spain) with O2 and CO2 sen-
sors, coupled to a SEDACOM infrared system to measure
activity. Respiratory quotient (RQ) is the ratio of carbon
dioxide production to oxygen consumption. Energy ex-
penditure was calculated using the Weir equation (EE =
1.44 x VO2 x (3.815 + 1.23 x RQ)).
Study 5: two diet preference tests
Two groups of 8 male 3-month old C57BL6/J mice were
tested. Every mouse received two diets, AIN-93 G and
AIN-93 G supplemented with 0.01% quinine HCl
(Group A) or with 0.1% quinine HCl (Group B). The
two diets were placed on the cage lid, separated by the
water bottle. The positions of the diets were switched
after 24 hours. The diets were weighed at the beginning
of the experiment, and 24 h and 48 hours later. The
amount consumed from each diet were calculated and
compared by paired Student T-tests.
Body composition
Body composition was determined in duplicate using an
EchoMRI-900 Body Composition Analyzer (Echo Med-
ical System, LLC, Houston, TX, USA).
Food intake
Food intake was calculated by weighing the diet and
subtracting the weight at the end of the measured period
from that at the beginning. Spillage of food on the bot-
tom of the cage was collected and weighed to ensure the
quality of food intake measurements.
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by wild-type C57BL6/J mice consuming AIN diet, AIN
diet + 0.1% quinine HCl or AIN diet +0.01% quinine
HCl, 7 male mice each. Mice were placed on a grid
above a piece of cardboard covering the bottom of the
cage for 72 h. Food powder and pellet crumbs were
separated from faeces and weighed.Analysis of faecal contents
Mice were placed on a grid for 72 h and faeces were col-
lected every 24 hours at the bottom of the cages which
were covered with a piece of absorbent cardboard to
minimise contamination of the faeces by urine. Faeces
collected during a 24 h period were vacuum oven-dried
(50°C, 24 hours) and weighed.
For measurement of caloric contents, the dried mater-
ial was turned into powder with a mortar. The powder
was compacted into two pellets using a Pellet Press 2811
(Parr Instrument Company, Moline, IL, USA). The dried
materials were added to 0.4 g benzoic acid and burned
in a 6100 Oxygen Bomb Calorimeter (Parr Instrument
Company) to measure their caloric content. Measure-
ments were done in duplicate.
For measurement of nitrogen content, 2 mg of dried
and homogenised faeces were placed in a sealed capsule
and inserted into an elemental analyser (CHNS-932,
Leco, St Joseph, MI, USA) and combusted at 1000°C in
presence of oxygen. The total contents of N in the sam-
ple were quantitatively converted to N2 and subse-
quently determined by measurement of the thermal
conductivity after separation of the gaseous components.
Measurements were done in quadruplicate.
Faecal lipids were measured as described [21]. Briefly,
lipids were extracted from 100 mg of dried faeces with
2 ml chloroform-methanol 2:1. The organic phase was
recovered and 1 ml of water was added to it. Following a
second centrifugation, the organic phase was recovered
and evaporated under N2 for 30 min and resuspended in
500 μl 1% Triton X 100 in Chloroform, evaporated
under N2 for 10 min and resuspended in 500 μl water.
The following commercial kits were used for the meas-
urement of lipids, according to the manufacturer’s
protocol: NEFA HR (2), Wako, Osaka, Japan, for free
fatty acids; TG PAP 150, BioMerieux, Marcy l’Etoile,
France for triglycerides; LabAssay Cholesterol, Wako,
for cholesterol, LabAssay Phospholipids, Wako, for
phospholipids.Blood parameters
Mice were food deprived for six hours, then glucose was
measured from a drop of blood obtained from an inci-
sion of the tail vein, using a glucometer (Ascensia Elite,
Bayer, Germany). The measures were done in duplicate.After measurement of glucose, the mice were anesthe-
tised with 3% isoflorane and blood was collected from the
aorta for the remaining measurements using commercial
kits (NEFA HR (2), Wako, for free fatty acids; TG PAP 150,
BioMerieux, Marcy l’Etoile, France for triglycerides; Ultra
Sensitive Mouse Insulin ELISA Kit, Crystal Chem, Downers
Grove, IL, USA, for insulin, and Roche reagents, Meylan,
France for ALT and AST) according to the manufacturer’s
protocol. Cytokines were measured using a multiplex im-
munoassay (Meso Scale Discovery, Gaithersburg, MD,
USA). The cytokines included in the multiplex assay are
Interleukin (IL)-1β, IL-12p70, Interferon-γ (INF-γ), IL-6,
keratinocyte chemoattractant (KC), IL-10, and Tumour Ne-
crosis Factor-α (TNF-α)Statistical analysis
Studies 1, 3 and 4
For all parameters except body weight, fat mass and lean
mass, the data were analysed with the General Linear
Model univariate of the statistics program SPSS with the
measured parameter as a within-subject factor and diet
as a between subject factor. When more than two
groups were compared and a significant difference was
found, a post hoc Tukey test was performed to determine
which groups differ.
For body weight, fat mass and lean mass, the data
were analyzed with the General Linear Model Repeated
Measures of the statistics program SPSS with the mea-
sured parameter as a within-subject factor and diet as a
between subject factor. When more than two groups
were compared and a significant difference was found, a
post hoc Tukey test was performed to determine which
groups differ.
For each cytokine the non-parametric Mann Whitney
test was used to assess the difference between control
and quinine fed mice and the results are presented as
medians.Study 2
The data were analyzed with the General Linear Model
of the statistics program SPSS with the measured param-
eter as a within-subject factor and diet and genotype as
between subject factors. The interaction diet*genotype
was also analyzed.
Data are presented as mean ± SEM. A p value <0.05
was considered significant.Competing interests
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